Cargando…
Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli
Type I modular polyketide synthases are responsible for potent therapeutic compounds that include avermectin (antihelinthic), rapamycin (immunosuppressant), pikromycin (antibiotic), and erythromycin (antibiotic). However, compound access and biosynthetic manipulation are often complicated by propert...
Autores principales: | Zhang, Guojian, Li, Yi, Fang, Lei, Pfeifer, Blaine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640655/ https://www.ncbi.nlm.nih.gov/pubmed/26601183 http://dx.doi.org/10.1126/sciadv.1500077 |
Ejemplares similares
-
Engineering Heterologous Production of Salicylate Glucoside and Glycosylated Variants
por: Qi, Ruiquan, et al.
Publicado: (2018) -
Probing the heterologous metabolism supporting 6‐deoxyerythronolide B biosynthesis in Escherichia coli
por: Zhang, Haoran, et al.
Publicado: (2009) -
Engineered Biosynthesis of the Antiparasitic Agent Frenolicin B and Rationally Designed Analogs in a Heterologous Host
por: Fitzgerald, Jay T., et al.
Publicado: (2011) -
Engineering the Erythromycin-Producing Strain Saccharopolyspora erythraea HOE107 for the Heterologous Production of Polyketide Antibiotics
por: Lü, Jin, et al.
Publicado: (2020) -
Developing E. coli-E. coli co-cultures to overcome barriers of heterologous tryptamine biosynthesis
por: Wang, Xiaonan, et al.
Publicado: (2019)